MedTrace Logo

Navigating the Grey Zone for Antenatal Corticosteroids

NCT04792112 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 460

Last updated 2022-06-02

No results posted yet for this study

Summary

The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.

Conditions

Interventions

BEHAVIORAL

Decision support tool

Decision support tool for late preterm antenatal corticosteroids

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Jessica Liauw, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-20
Primary Completion
2024-02-01
Completion
2024-02-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792112 on ClinicalTrials.gov